HEMOLYTIC ANEMIA
Keywords:
Anemia, diseases, treatments, WHO, MCV, Hemolytic anemia, purple bloodAbstract
Hemolytic anemia is a type of anemia characterized by the premature destruction of red blood cells, leading to a reduction in the number of red blood cells in the circulation. This condition can be caused by a variety of factors, including genetic mutations, autoimmune disorders, and infections. In this article, we will provide a comprehensive review of the pathophysiology, clinical presentation, and treatment options for hemolytic anemia.
Downloads
References
Ataga KI, Gordeuk VR, Agodoa I, Colby JA, Gittings K, Allen IE. Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis. PLoS One. 2020;15(4): e0229959.
Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2020 May; 41:100648.
Qian Q, Nath KA, Wu Y, Daoud TM, Sethi S. Hemolysis and acute kidney failure. Am J Kidney Dis. 2010 Oct;56(4):780-4.
Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005 Oct 01;72(7):1277-82.
Walshe JM. The acute haemolytic syndrome in Wilson's disease--a review of 22 patients. QJM. 2013 Nov;106(11):1003-8.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.